Ampollas

Avian (chicken) sternum cartilage is the primary commercial source of undenatured type II collagen (UC-II), which has been studied in multiple RCTs for OA and joint health. UC-II at 40 mg/day operates via oral tolerance mechanisms and has been shown in clinical trials to improve joint comfort and function, including in athletes with activity-related knee pain. It outperforms glucosamine+chondroitin in some head-to-head studies.

Boron is a trace mineral that influences bone and joint health by modulating calcium metabolism, sex steroid hormones, and inflammatory cytokines. Epidemiological data show lower OA prevalence in regions with higher boron soil/water content. A small RCT in OA patients found boron supplementation (6 mg/day for 8 weeks) significantly reduced pain and improved joint function compared to placebo.

Boswellia serrata (Indian frankincense) is an Ayurvedic herb whose active boswellic acids, particularly AKBA, selectively inhibit 5-lipoxygenase and leukotriene synthesis, reducing joint inflammation. A 2020 meta-analysis of seven RCTs (545 patients) showed Boswellia significantly reduced OA pain, stiffness, and physical function scores. A 2025 network meta-analysis of 4,599 KOA patients ranked Boswellia as having the highest probability of being most effective for pain and stiffness.

Boswellic acids are the active triterpenic compounds in Boswellia serrata, with AKBA being the most potent anti-inflammatory component via 5-LOX inhibition. A meta-analysis of seven clinical RCTs (545 patients) confirmed boswellic acid-containing extracts significantly reduce OA pain, stiffness, and functional impairment. A 2025 network meta-analysis ranked boswellic acid extracts highest among seven supplements for KOA pain and stiffness reduction.

Bovine cartilage is a concentrated natural source of type II collagen, chondroitin sulfate, and glycosaminoglycans used to support joint structure and mobility. Clinical use of bovine cartilage extracts has been investigated for osteoarthritis, with evidence for reductions in joint pain and stiffness paralleling those of isolated chondroitin sulfate. It provides structural substrates for cartilage matrix maintenance.

Bromelain is a proteolytic enzyme complex derived from pineapple stem with anti-inflammatory and anti-edematous properties relevant to joint conditions. Studies show bromelain reduces pro-inflammatory markers (MMP-3, MMP-13, IL-6, PGE2) in synovial cells (PMC8515758). It has been used in European phytotherapy for joint inflammation and is listed in the German Commission E monograph for soft tissue swelling.

Cat's Claw (Uncaria tomentosa) is an Amazonian vine used traditionally for arthritis and inflammatory joint conditions. Its oxindole alkaloids and procyanidins inhibit TNF-α and NF-κB, reducing joint inflammation. A small double-blind RCT in knee OA found a 12-week preparation reduced WOMAC pain scores significantly; ConsumerLab lists it among evidence-supported joint supplements.

Centella triterpenes (asiatic acid, madecassic acid, asiaticoside, madecassoside) are the bioactive components of Centella asiatica that stimulate collagen synthesis in connective tissue. EMA-approved for venous insufficiency with collagen-related mechanisms directly applicable to joint connective tissue. Multiple in vitro and animal studies confirm anti-inflammatory and matrix-remodeling properties relevant to joint flexibility.

Cetylated fatty acids (CFA) are a class of esterified fatty acids studied for knee osteoarthritis. A 2025 randomized double-blind placebo-controlled trial (n=60, grade 3–4 knee OA, 1.5 g/day for 60 days) found CFA produced statistically significant reductions in pain VAS (−1.7 cm vs. −0.6 cm for placebo, p<0.005) and observed improvements in range of motion (ROM). The mechanism involves modulation of fatty acid composition in joint membranes.

Chondroitin sulfate is a sulfated glycosaminoglycan naturally present in cartilage extracellular matrix. Systematic reviews and RCTs demonstrate it reduces collagenolytic activity, supports proteoglycan production, and improves pain and function in knee osteoarthritis. When combined with glucosamine, a 2-year RCT found only half the joint space narrowing compared to placebo. Standard dose is 800–1,200 mg/day.

Cissus quadrangularis is an Ayurvedic herb traditionally used for bone and joint healing. RCTs have demonstrated it reduces joint pain and stiffness and accelerates recovery from musculoskeletal injuries. Its phytosterols, including osteogenic sterols and ketosterones, are proposed to support collagen synthesis and cartilage integrity.

Hydrolyzed collagen peptides and undenatured type II collagen have been studied in RCTs for osteoarthritis and joint pain. A meta-analysis of RCTs (PMC10505327) confirmed significant pain reduction in knee OA patients vs. placebo. A 2025 RCT of hydrolyzed collagen peptides showed significant WOMAC improvements at weeks 1, 4, and 8. A 2025 network meta-analysis of 4,599 KOA patients also ranked collagen among supplements with meaningful benefit.

Clinical trials in osteoarthritis and ankle sprains consistently report improved mobility and range of motion with topical comfrey preparations versus placebo. A double-blind RCT in 142 ankle-sprain patients showed statistically significant superiority for ankle mobility (neutral zero method) compared to placebo. Post-marketing surveillance in patients with joint and muscle complaints found morning joint stiffness reduced by 94% (from 17 to 1 minute) after a median 11.5 days of treatment.

Curcumin is the principal bioactive curcuminoid of turmeric with extensive RCT evidence for reducing OA pain, joint stiffness, and physical functional limitation. A 2025 network meta-analysis (39 RCTs, 4,599 KOA patients) confirmed curcumin demonstrated benefits in joint function outcomes and was ranked among the most effective supplements. Multiple systematic reviews confirm it reduces inflammatory markers relevant to joint mobility.

Curcuminoids are the active phenolic compounds of turmeric (curcumin, bisdemethoxycurcumin, demethoxycurcumin) responsible for its anti-inflammatory and joint-protective properties. Standardized curcuminoid extracts (≥95% curcuminoids) have been evaluated in multiple RCTs for knee OA, showing significant improvements in pain and physical function. A 2025 network meta-analysis of 39 RCTs ranked curcuminoids among the most effective supplements for KOA function improvement.

Devil's Claw (Harpagophytum procumbens), used traditionally by San peoples of southern Africa for joint pain, contains harpagoside with well-documented anti-inflammatory and analgesic properties. Four double-blind clinical trials using 2,000–4,500 mg/day extract demonstrated significant reductions in pain and improvements in mobility on VAS, WOMAC, and finger-floor measures. A 12-week multicenter surveillance study (n=75, 2,400 mg/day) showed ~23% improvement across all WOMAC subscales.

Fish oil provides EPA and DHA omega-3 fatty acids that reduce synovial inflammation by modulating prostaglandin and leukotriene biosynthesis. Clinical evidence supports reductions in morning stiffness and joint tenderness, particularly in rheumatoid arthritis. Fish oil is one of the most studied nutritional supplements with hundreds of clinical trials examining its anti-inflammatory role in joint tissue.

Ginger (Zingiber officinale) contains gingerols and shogaols that inhibit both COX and LOX inflammatory pathways, reducing joint inflammation. A 2025 network meta-analysis of 39 RCTs (4,599 KOA patients) found ginger demonstrated benefits in some WOMAC outcomes for knee OA. Ginger has been used in Ayurvedic medicine for centuries as 'Shunthi' for joint stiffness.

Glucosamine is an aminomonosaccharide that serves as a building block for cartilage proteoglycans and glycosaminoglycans. Multiple RCTs and systematic reviews document improvements in joint pain, stiffness, and physical function in osteoarthritis patients. A 2025 systematic review of 146 studies found over 90% of efficacy studies reported positive outcomes for osteoarthritis and joint pain. Typical oral dose is 1,500 mg/day of glucosamine sulfate.

Glycosaminoglycans (GAGs) are long-chain polysaccharides—including chondroitin sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate—that form the structural backbone of cartilage and synovial fluid. They are essential for joint lubrication, shock absorption, and cartilage integrity. Clinical supplements of specific GAGs (chondroitin, hyaluronic acid) have documented evidence for improving joint mobility in osteoarthritis.

Green-lipped mussel (Perna canaliculus, GLM) is a New Zealand shellfish rich in unique omega-3 fatty acids (including rare ETA) and glycosaminoglycans. A 2021 systematic review of nine clinical trials found GLM produced moderate, clinically significant reductions in OA pain. A 2023 PLOS ONE study confirmed GLM reduced arthritis severity and pro-inflammatory cytokines in a CIA model.

Guggul (Commiphora mukul) is an Ayurvedic resinous gum whose active guggulsterones exert anti-inflammatory effects via inhibition of NF-κB and reduction of inflammatory cytokines. Clinical studies in osteoarthritis have shown improvements in joint pain and function. Guggul has been used in Ayurvedic medicine for thousands of years for joint disorders ('Amavata').

Guggulsterones (E- and Z-isomers from Commiphora mukul) are the principal anti-inflammatory bioactives of Guggul, inhibiting NF-κB and reducing joint inflammatory cytokines. RCTs have demonstrated improvements in OA pain and function with standardized guggulsterone preparations. They are the characterized active markers referenced in Ayurvedic pharmacopeia for joint health.

Harpagoside is the principal active iridoid glycoside from Harpagophytum procumbens (Devil's Claw) responsible for its anti-inflammatory and analgesic properties in joint conditions. Clinical trials with devil's claw preparations standardized to 30–100 mg harpagoside daily have shown significant improvements in mobility and pain in OA of the hip and knee. EMA recommends >50 mg harpagoside per day for musculoskeletal indications.

Hyaluronic acid (HA) is a key glycosaminoglycan in synovial fluid that maintains joint viscosity, cushioning, and lubrication. Intra-articular HA injection has long-established clinical use; oral HA has been evaluated in a double-blind placebo-controlled 12-month study and showed alleviation of knee OA symptoms. HA improves synovial fluid elasticity, decreases pain-producing neuropeptides, and exerts anti-inflammatory effects including IL-1 suppression.

Multiple clinical RCTs in osteoarthritis consistently report improved joint flexion, range of motion, and walking distance with Boswellia supplementation. A 2024 double-blind RCT showed measurable improvements within 5 days of starting supplementation. Kimmatkar et al. (2003) documented increased knee flexion and walking distance vs. placebo.

Ipriflavone is a synthetic isoflavone derivative primarily studied for bone density and osteoporosis prevention. Clinical trials demonstrate it inhibits bone resorption and may support the bone-joint interface relevant to mobility. Multiple European RCTs and a Cochrane review confirm its effect on bone mineral density; secondary benefits for joint mobility stem from improved bone support.

Krill oil provides EPA and DHA in phospholipid form alongside astaxanthin, with anti-inflammatory properties relevant to joint health. A 6-month multicenter double-blind placebo-controlled RCT (PMC9437987) found krill oil resulted in modest but significant improvements in knee OA pain, stiffness, and physical function. A 2025 network meta-analysis (39 RCTs, 4,599 KOA patients) ranked krill oil among supplements showing potential for function improvement.

Magnesium is an essential mineral required for over 300 enzymatic reactions, including those involved in collagen synthesis, cartilage matrix maintenance, and muscle relaxation. Low magnesium status is associated with higher levels of inflammatory markers (CRP, IL-6) and increased joint stiffness. Supplementation supports muscle flexibility and reduces cramps that impair joint mobility.

MSM is an organosulfur compound studied in multiple RCTs for joint pain and physical function, particularly in knee osteoarthritis. A pivotal 2006 RCT (3 g twice daily for 12 weeks) showed MSM significantly reduced WOMAC pain scores by 25.1% vs. 13.7% for placebo. A 2023 Nutrients RCT confirmed improvements in knee quality-of-life in mild knee pain. Evidence is rated 'strong' across 13 peer-reviewed studies.

Several clinical trials have used range of motion as a primary or secondary outcome for CMO. The 1997 Siemandi RCT measured range of motion across arthritis populations; the 2002 knee OA RCT found statistically significant improvement in knee flexion (10.1 degrees vs. 1.1 degrees on placebo). A knee OA trial using a plant-derived CFA extract reported CMO effective at alleviating knee pain and improving function.

Omega-3 fatty acids (EPA and DHA) are well-established anti-inflammatory compounds that reduce joint tenderness, morning stiffness, and synovial inflammation, particularly in rheumatoid arthritis and osteoarthritis. Studies show omega-3 supplementation reduces pro-inflammatory eicosanoids and cytokines directly relevant to joint flexibility and mobility. Multiple systematic reviews and meta-analyses support their use in inflammatory joint conditions.

Osthole is a coumarin compound from Cnidium monnieri used in traditional Chinese medicine for joint and bone conditions. In vitro and animal studies demonstrate osthole inhibits NF-κB and MAPK inflammatory pathways, reduces osteoclast activity, and promotes chondrogenesis. It has been used in TCM for 'Bi syndrome' (wind-cold-damp joint conditions with pain and stiffness).

Palmitoylethanolamide (PEA) is an endogenous fatty acid amide with analgesic and anti-inflammatory properties relevant to joint pain and stiffness. It activates PPAR-α receptors, reducing neuroinflammation and mast cell degranulation in periarticular tissues. A 2019 meta-analysis confirming significant pain reduction and a 2021 RCT specifically in knee OA patients support its evidence base for joint pain and mobility.

SAMe (S-adenosylmethionine) is a naturally occurring sulfur-containing compound evaluated in multiple RCTs for osteoarthritis. A meta-analysis of 11 RCTs found SAMe more effective than placebo in reducing functional limitation (ES=0.31), and as effective as NSAIDs for pain relief and functional improvement with fewer side effects. NCCIH (NIH) recognizes clinical evidence for SAMe in OA management.

Serrapeptase (serratiopeptidase) is a proteolytic enzyme isolated from Serratia marcescens that reduces edema, fibrin deposits, and inflammatory mediators in joint tissues. Clinical studies show it reduces post-surgical swelling, improves range of motion, and reduces joint pain and stiffness in arthritis patients. It is widely used in Europe and Asia as an anti-inflammatory enzyme supplement.

Serratiopeptidase is the same enzyme as serrapeptase—a serine protease with anti-inflammatory and anti-edematous properties relevant to joint conditions. Clinical RCTs demonstrate it reduces joint swelling, stiffness, and pain while improving range of motion in musculoskeletal conditions. It is approved in several countries for inflammatory joint conditions and trauma-related mobility limitation.

Shark cartilage is a source of chondroitin sulfate and other glycosaminoglycans used as a dietary supplement for joint health. Clinical evidence is primarily derived from its chondroitin sulfate content; some RCTs in OA patients have shown reductions in joint pain and improvements in function. Evidence is less robust than for purified chondroitin sulfate alone, with mixed results in large trials.

Sinomenium acutum (Qing Feng Teng) is a TCM herb whose alkaloid sinomenine is approved as a prescription drug in China for rheumatoid arthritis and joint inflammation. Multiple RCTs in China demonstrate sinomenine significantly reduces joint pain, swelling, and functional limitation compared to placebo or standard treatments. It is one of the best-characterized TCM anti-arthritic alkaloids.

Turmeric (Curcuma longa) and its active curcuminoids have robust clinical evidence for improving joint pain and physical function in osteoarthritis. A 2021 BMJ Open Sport & Exercise Medicine review confirmed significant improvement in pain relief and physical function for knee OA. A 2025 network meta-analysis of 39 RCTs (4,599 KOA patients) ranked curcumin/turmeric among the supplements with significant functional benefits.

Vitamin D is an essential fat-soluble vitamin whose deficiency is strongly associated with increased joint pain, muscle weakness, and impaired musculoskeletal function. Multiple clinical studies and meta-analyses document associations between low vitamin D and worsened OA outcomes, and supplementation has been shown to improve muscle strength and physical function relevant to joint mobility.

Vitamin D3 (cholecalciferol) is the more bioavailable form of vitamin D, essential for musculoskeletal health, chondrocyte function, and muscle physiology relevant to joint mobility. Deficiency correlates with worsened OA outcomes and impaired physical function. A 2025 network meta-analysis of 39 RCTs for knee OA included vitamin D among evaluated supplements, and supplementation improves muscle strength and physical performance tests.

Achyranthes bidentata (Niu Xi, Ox Knee) root is a TCM herb listed in the Chinese Pharmacopoeia for joint conditions, specifically described as guiding herbs to the lower limbs, strengthening tendons and bones, and treating pain and weakness of the lumbar and knee joints. Active ecdysteroids and saponins support bone and cartilage metabolism with anti-inflammatory properties.

Centella asiatica provides triterpenic saponins (asiaticoside, madecassoside) that stimulate fibroblast collagen synthesis, directly relevant to connective tissue and joint integrity. Traditional Ayurvedic use for arthritis and joint pain ('Mandukparni') is well-documented. Modern phytochemical research confirms its collagen-stimulating and anti-inflammatory properties relevant to flexibility and connective tissue support.

Chondrus crispus (Irish moss) is a red algae traditionally used in Celtic herbal medicine as a demulcent and anti-inflammatory for joint and connective tissue complaints. It is a rich natural source of carrageenan and sulfated polysaccharides with glycosaminoglycan-like structural features. Traditional use predates clinical validation; limited modern research exists specifically for flexibility and mobility.

Corydalis yanhusuo (Yan Hu Suo) rhizome is a major TCM analgesic and anti-inflammatory herb listed in the Chinese Pharmacopoeia for musculoskeletal pain and promoting blood circulation to relieve stiffness. Its alkaloid tetrahydropalmatine (THP) has been confirmed in clinical and pharmacological studies to have significant analgesic properties relevant to joint mobility. Used in TCM for over 1,000 years for 'moving qi and blood to relieve pain.'

Dipsacus asperoides (Xu Duan, teasel root) is a classical TCM herb specifically for bone and joint conditions, listed in the Chinese Pharmacopoeia for alleviating pain in the loins and knees and strengthening tendons and bones. Active iridoid glycosides support bone and cartilage metabolism. Used for over 2,000 years in TCM for musculoskeletal weakness and joint mobility impairment.

Drynaria (Gu Sui Bu, Drynaria roosii/fortune) rhizome is a TCM herb specifically used for bone fractures, joint pain, and musculoskeletal weakness. Active naringenin and naringin glycosides stimulate osteoblastogenesis and reduce osteoclast activity. The Chinese Pharmacopoeia formally lists Drynaria for strengthening bone and relieving joint pain.

Eucommia (Eucommia ulmoides) bark is one of the most important tonics in traditional Chinese medicine, specifically used for musculoskeletal weakness, joint pain, and impaired mobility. Modern research shows its active compounds (chlorogenic acid, aucubin, geniposidic acid) support collagen synthesis and bone mineral density. TCM classifies it as a 'kidney and liver tonic' that strengthens tendons and bones.

Eucommia ulmoides (Du Zhong) bark is formally listed in the Chinese Pharmacopoeia for strengthening tendons, bones, and the lumbar region—a direct reference to flexibility and mobility support. Modern studies confirm its chlorogenic acid, aucubin, and lignan constituents support collagen synthesis, bone density, and anti-inflammatory properties relevant to joint function.

Gentiana macrophylla (Qin Jiao, Large-leaf Gentian) root is listed in the Chinese Pharmacopoeia specifically for joint conditions, described as eliminating wind-dampness, relaxing tendons and muscles, and reducing fever in bones. It is a key herb for 'Bi syndrome' (joint pain/stiffness) with active iridoid glycosides showing anti-inflammatory properties confirmed in modern research.

Gotu Kola (Centella asiatica) has been used in Ayurvedic and traditional Chinese medicine for connective tissue repair, wound healing, and joint health. Its triterpenic saponins (asiaticoside, madecassoside) stimulate collagen synthesis and improve connective tissue integrity. While primary clinical evidence focuses on wound healing and venous insufficiency, traditional use for joint flexibility and connective tissue support is well-documented.

Horsetail (Equisetum arvense) is traditionally used in European and Ayurvedic herbal medicine for connective tissue support and joint health, attributed to its exceptionally high silicon (silica) content. Silicon plays a key role in collagen cross-linking and glycosaminoglycan synthesis. German Commission E and ESCOP recognize horsetail for supportive treatment of connective tissue and bone conditions.

Qin Jiao (Gentiana macrophylla root) is formally listed in the Chinese Pharmacopoeia for wind-dampness joint conditions, specifically described as 'relaxing tendons and muscles' and treating musculoskeletal pain and stiffness. It is a classic anti-rheumatic TCM herb with iridoid glycoside constituents that inhibit inflammatory pathways confirmed in modern pharmacological studies.

Traditional Western and Chinese herbal medicine uses Solomon's seal to restore flexibility and mobility in stiff or injured joints, tendons, and ligaments. The herb is described as normalizing connective tissue tension—loosening over-tight structures and firming over-lax ones. This application is well-documented in herbalist literature but lacks clinical trial data.

Spatholobus suberectus (Ji Xue Teng, Millettia vine) stem is used in TCM specifically for joint conditions including arthritis and muscle-tendon stiffness. Active catechins, epicatechin, and formononetin exert anti-inflammatory and antioxidant effects. The Chinese Pharmacopoeia lists it for 'replenishing blood, activating blood circulation, and relaxing tendons.'